Cargando…
Changes in Drug Clinical Trials of Thyroid Diseases in China, 2009–2022
OBJECTIVE: The incidence rate of thyroid diseases increased worldwide. This study aims to overview the changing landscape of drug clinical trials on thyroid disease during 2009–2022. METHODS: The detailed information of thyroid disease drug trials registered on the National Medical Products Administ...
Autores principales: | Li, Chen, Hao, Jun, Wang, Chuangshi, Yang, Jie, Zheng, Yitian, Zhang, Kuo, Hui, Wen, Meng, Xiangbin, Gao, Jun, Li, Wei, Tang, Yi-Da |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Dove
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10407876/ https://www.ncbi.nlm.nih.gov/pubmed/37559911 http://dx.doi.org/10.2147/DDDT.S409617 |
Ejemplares similares
-
The changing landscape of drug clinical trials on cardiometabolic diseases in China, 2009–2021
por: Li, Chen, et al.
Publicado: (2023) -
Level of evidence supporting the Chinese cardiovascular disease clinical practice guidelines and its evolution in the past two decades
por: Li, Chen, et al.
Publicado: (2023) -
The Impact of the Triglyceride-Glucose Index on Poor Prognosis in NonDiabetic Patients Undergoing Percutaneous Coronary Intervention
por: Yang, Jie, et al.
Publicado: (2021) -
Elevated HsCRP in Chronic Obstructive Pulmonary Disease: A Prospective Study of Long-Term Outcomes After Percutaneous Coronary Intervention
por: Zheng, Yitian, et al.
Publicado: (2022) -
Extensively Drug-Resistant Tuberculosis, Central China, 2007–2009
por: Shi, Dawei, et al.
Publicado: (2012)